Search results

Evidence-based recommendations on focal therapy using high-intensity focused ultrasound for localised prostate cancer. This involves using high-intensity focused ultrasound to heat up and destroy only the areas of the prostate with cancer (focal therapy). The aim is to destroy the cancer while reducing damage to healthy prostate tissue.

Result type

Interventional procedures guidance

Published

5 April 2023

Evidence-based recommendations on biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer. This involves pushing the rectum slightly away from the prostate by inserting a balloon or injecting a gel (spacer) between them.

Result type

Interventional procedures guidance

Published

7 February 2023

Evidence-based recommendations on high dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer. This involves using radiotherapy to treat the cancer from both outside of the body and from within the affected area.

Result type

Interventional procedures guidance

Published

24 May 2006

This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer.

Result type

NICE guideline

Published

25 February 2015

This guideline covers how healthcare services for people with urological cancer should be organised. It aims to improve care by recommending which healthcare professionals should be involved and the types of hospital or cancer centre best suited to provide the care.

Result type

Cancer service guideline

Published

19 September 2002

This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.

Result type

Clinical guideline

Last updated

26 April 2023

NG12/05 Question Prostate-specific antigen testing: What is the diagnostic accuracy of using age-adjusted and fixed...

Result type

Research recommendation

Published

7 January 2022

Abiraterone for treating newly diagnosed high risk metastatic hormone-naive prostate cancer [ID945] 3 September 2020 TBC Afamelanotide...

investigations for CPG 3 prostate cancer: What is the diagnostic accuracy of staging investigations for CPG 3 prostate...

Result type

Research recommendation

Published

7 January 2022

A review of the impact our evidence-based guidance has on improvements in lung cancer.

clinically and cost-effective pathway for diagnosing clinically significant prostate cancer? Any explanatory notes(if applicable) Why...

Result type

Research recommendation

Published

25 October 2019

Register an interest in this interventional procedure   ...

Result type

Interventional procedures guidance

Status

Topic selection

clinically and cost-effective pathway for diagnosing clinically significant prostate cancer? Any explanatory notes(if applicable) Why...

Result type

Research recommendation

Published

7 January 2022

Evidence-based recommendations on transperineal template biopsy of the prostate. This involves inserting many fine needles though the skin between the scrotum and the anus in order to obtain tissue samples from the prostate for testing.

Result type

Interventional procedures guidance

Published

27 October 2010

This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.

Result type

Clinical guideline

Last updated

7 February 2017